LISA CASTRO: Open Payments
NPI 1750755484 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$799 in 25 payments from 12 companies in 2025. Trend: 2023 $232 · 2024 $726 · 2025 $799
Food & beverage: $799
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $314 |
| Medtronic, Inc. | 1 | $128 |
| Novartis Pharmaceuticals Corporation | 4 | $75 |
| Merck Sharp & Dohme LLC | 4 | $58 |
| CVRx, Inc. | 2 | $51 |
| PFIZER INC. | 2 | $36 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| Actelion Pharmaceuticals US, Inc. | 1 | $24 |
| SCPHARMACEUTICALS INC. | 1 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
Products named: REPATHA, AFFERA MAPPING SYSTEM, LEQVIO, ELIQUIS, Barostim Neo System, EVKEEZA, CAPVAXIVE, VERQUVO.
Industry payments across TX — which companies pay providers there.
